Study guide

Section 13.3: Systemic Nutrition, Hydration & Pain Management

ABWM Certified Wound Specialist CWS

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Exam Overview

1.1 About the ABWM CWS Exam 1.2 How to Use This Study Guide & Blueprint Strategy

2 Chapter 2: Comprehensive Patient & Wound Assessment

2.1 Patient History & Systemic Risk Factors 2.2 Physical Examination & Anatomical Wound Classification 2.3 Quantitative Wound Measurement & Documentation 2.4 Bioburden & Infection Assessment

3 Chapter 3: Vascular Assessment & Diagnostic Testing

Section 3.1: Ankle-Brachial Index (ABI) & Toe-Brachial Index (TBI) Interpretation Section 3.2: Advanced Vascular Diagnostics Section 3.3: Neuropathic & Sensory Assessment

4 Chapter 4: Laboratory, Imaging & Diagnostic Approaches

Section 4.1: Laboratory Evaluation in Wound Care Section 4.2: Imaging Modalities for Wounds & Bone Section 4.3: Differential Diagnosis of Recalcitrant & Atypical Wounds

5 Chapter 5: Physiology of Wound Healing & Tissue Repair

5.1 Hemostasis & Inflammatory Phase Dynamics 5.2 Proliferative & Remodeling Phases 5.3 Growth Factors & Extracellular Matrix (ECM)

6 Chapter 6: Biofilm Biology & Wound Bed Preparation

6.1 Biofilm Pathophysiology & Management Strategies 6.2 TIME Framework & Wound Bed Preparation 6.3 Moisture Balance & Exudate Management

7 Chapter 7: Pressure Injuries & Moisture-Associated Skin Damage

7.1 Pressure Injury Pathophysiology & NPIAP Staging 7.2 Risk Assessment Tools & Support Surface Selection 7.3 Moisture-Associated Skin Damage (MASD) & Incontinence-Associated Dermatitis

8 Chapter 8: Lower Extremity Ulcers (Venous, Arterial & Mixed)

Section 8.1: Venous Leg Ulcers & CEAP Classification Section 8.2: Arterial Ulcers & Peripheral Artery Disease Section 8.3: Mixed Venous-Arterial Ulcers & Lymphedema

9 Chapter 9: Diabetic Foot Ulcers & Neuropathic Wounds

Section 9.1: Diabetic Foot Ulcer Pathophysiology & Classification Section 9.2: Diabetic Foot Infection & Osteomyelitis Management

10 Chapter 10: Thermal Injuries, Surgical Wounds & Special Etiologies

Section 10.1: Burn Injuries & Thermal Damage Section 10.2: Surgical Wounds, Dehisced Incisions & Fistulas Section 10.3: Dermatological, Pediatric & Miscellaneous Wound Types

11 Chapter 11: Debridement & Topically Applied Therapies

Section 11.1: Debridement Modalities & Selection Section 11.2: Wound Dressing Selection & Categories Section 11.3: Topical Antimicrobial Agents & Antiseptics

12 Chapter 12: Compression Therapy & Advanced Off-Loading

Section 12.1: Compression Therapy Modalities & Science Section 12.2: Off-Loading Devices & Biomechanical Protection

13 Chapter 13: Advanced & Adjunctive Wound Therapies

Section 13.1: Negative Pressure Wound Therapy (NPWT) Section 13.2: HBOT, Biophysical Agents & Advanced Biologics Section 13.3: Systemic Nutrition, Hydration & Pain Management

14 Chapter 14: Professional Practice, Reimbursement & Interprofessional Care

14.1 Professional Ethics, Scope of Practice & ABWM Guidelines 14.2 Documentation, Coding & Reimbursement Standards 14.3 Interprofessional Team Roles & Quality Improvement

Section 13.3: Systemic Nutrition, Hydration & Pain Management

Key Takeaways Explain This Topic AI

Energy requirements for chronic wound healing and Stage 3-4 pressure injuries scale to 30-35 kcal/kg/day, while protein demands increase to 1.2-1.5 g/kg/day (up to 2.0 g/kg in severe burns/trauma).

Vitamin C is essential for proline and lysine hydroxylation in collagen synthesis; deficiency causes scurvy and wound breakdown.

Zinc is a cofactor for >300 enzymes including DNA/RNA polymerases and MMPs; Vitamin A uniquely reverses corticosteroid-induced suppression of wound inflammation.

L-Arginine serves as a precursor to nitric oxide and enhances collagen deposition, while L-Glutamine fuels rapidly dividing enterocytes and leukocytes.

Hydration targets 30 mL/kg/day; wound pain management requires distinguishing background, procedural, and breakthrough pain and using multimodal WHO ladder pharmacotherapy and soft silicone contact layers.

Last updated: July 2026

Section 13.3: Systemic Nutrition, Hydration & Pain Management

Wound healing is a complex, energy-demanding metabolic process requiring extensive synthesis of new proteins, cellular division, and extracellular matrix deposition. No topically applied dressing or advanced technology can overcome the metabolic handicap imposed by systemic protein-calorie malnutrition, micronutrient deficiency, chronic dehydration, or unmanaged wound pain. The Certified Wound Specialist (CWS) must approach wound healing holistically, conducting comprehensive nutritional assessments, scaling macronutrient and micronutrient intake to wound severity, maintaining fluid homeostasis, and executing evidence-based multimodal pain management.

Macronutrient Requirements: Energy & Protein Scaling

The body's metabolic response to tissue injury, chronic inflammation, or major surgical trauma is characterized by hypermetabolism and catabolism. Endogenous amino acids are mobilized from skeletal muscle to synthesize acute-phase proteins, repair extracellular matrix, and fuel immune cell function.

Energy (Caloric) Demands

Energy needs must be elevated to prevent the body from metabolizing endogenous protein reserves for basal energy needs (gluconeogenesis).

Baseline Adult Requirement: 25 to 30 kcal/kg body weight/day.

Wound Healing & Pressure Injury Requirement: 30 to 35 kcal/kg body weight/day for individuals with Stage 3, Stage 4, or unstageable pressure injuries, large surgical wounds, or chronic non-healing ulcers.

Underweight / Severely Catabolic Requirement: Up to 35 to 40 kcal/kg/day to promote weight gain and anabolic tissue repair.

Protein Requirements & Nitrogen Balance

Protein is the single most critical macronutrient for tissue repair. Fibroblast proliferation, collagen synthesis, angiogenesis, and immune function depend entirely on adequate amino acid availability.

  • Patient Category Protein Target Clinical Rationale Monitoring
  • Healthy Adult (RDA) 0.8 g / kg / day Basal maintenance Nitrogen balance

Stage 3 & 4 Pressure Injuries / Healing Wounds 1.2–1.5 g / kg / day Anabolic matrix synthesis & repair BUN, eGFR, serum prealbumin

Severe Burns / Major Traumatic Injury 1.5–2.0 g / kg / day Extreme catabolism & nitrogen loss Daily nitrogen balance studies

Compromised Renal Function (CKD/ESRD) Scaled to eGFR (0.8–1.0 g/kg) Prevent uremic toxicity Close nephrology co-management

Elevated Intake (1.2–1.5 g/kg/day): Patients with Stage 3 or 4 pressure injuries, deep diabetic ulcers, or extensive dehisced surgical wounds require 1.2 to 1.5 grams of protein per kilogram of body weight daily (nearly double the standard RDA of 0.8 g/kg/day).

Hypermetabolic Intake (1.5–2.0 g/kg/day): Major thermal burns, extensive trauma, or open abdominal wounds require up to 2.0 g/kg/day.

Renal & Hepatic Considerations: In patients with Chronic Kidney Disease (CKD) not on dialysis or End-Stage Renal Disease (ESRD), high protein loading can precipitate uremic encephalopathy or fluid-electrolyte collapse. Protein intake must be carefully co-managed with nephrology based on blood urea nitrogen (BUN) and estimated glomerular filtration rate (eGFR).

Specific Micronutrients & Conditional Amino Acids

Micronutrients serve as indispensable coenzymes and antioxidants across all phases of tissue repair.

1. Vitamin C (Ascorbic Acid)

Mechanism: Required cofactor for the enzymes prolyl hydroxylase and lysyl hydroxylase , which hydroxylate proline and lysine residues during intracellular procollagen synthesis. Hydroxylation is essential for forming stable inter-chain hydrogen bonds in the collagen triple helix.

Deficiency Impact: Severe deficiency causes scurvy , characterized by defective collagen synthesis, capillary fragility, petechiae, wound dehiscence, and complete failure of granulation.

Clinical Dosing: 500 to 1000 mg daily in divided doses for healing wounds.

2. Zinc

Mechanism: Essential cofactor for over 300 metalloenzymes, including DNA/RNA polymerases (required for cellular mitosis) and Matrix Metalloproteinases (MMPs) (required for wound debridement and remodeling).

Deficiency Impact: Impaired cell division, delayed re-epithelialization, reduced tensile strength, and blunted cell-mediated immunity.

Clinical Dosing: 220 mg zinc sulfate (50 mg elemental zinc) daily for 14 days max; prolonged high-dose supplementation (>40 days) must be avoided as it induces copper deficiency and secondary anemia.

3. Vitamin A (Retinol)

Mechanism: Stimulates epithelialization, fibrogenesis, and cross-linking of extracellular matrix proteins.

Corticosteroid Reversal: Uniquely, Vitamin A reverses the inhibitory effects of systemic corticosteroids on inflammatory response and wound healing without blunting systemic anti-inflammatory actions.

Clinical Dosing: 10,000 to 25,000 IU orally daily for 7 to 10 days in patients receiving chronic systemic steroid therapy.

4. Conditionally Essential Amino Acids: L-Arginine & L-Glutamine

L-Arginine: Precursor to nitric oxide (NO) , a key vasodilator and antimicrobial signaling molecule. Arginine stimulates insulin-like growth factor-1 (IGF-1), enhances collagen accumulation, and boosts T-lymphocyte proliferation.

L-Glutamine: Primary metabolic fuel for rapidly dividing cells, particularly enterocytes (maintaining gut mucosal barrier to prevent bacterial translocation) and inflammatory leukocytes (neutrophils and macrophages) at the wound site.

Systemic Hydration & Fluid Homeostasis

Water constitutes approximately 60% of total body mass and is the primary medium for microvascular nutrient transport, waste clearance, and cellular turgor.

Fluid Requirement Calculation: Baseline hydration requirement is 30 mL per kilogram of body weight per day (or 1.0 to 1.5 mL per kcal consumed), with a minimum target of 1500 mL/day in non-restricted adults.

Elevated Losses: Fluid needs must be scaled upward for patients with heavy wound exudate, NPWT canister losses, fever, high-output fistulas, or air-fluidized support beds.

Dehydration Impact: Hypovolemia causes peripheral vasoconstriction via sympathetic stimulation, reducing skin perfusion, lowering TcPO2, causing cell desiccation, and halting wound contraction.

Fluid Restrictions: In congestive heart failure (CHF) or end-stage renal disease (ESRD), hydration must be monitored via daily weights and peripheral edema rather than blanket volume expansion.

Comprehensive Wound Pain Management Framework

Wound-related pain is a complex bio-psychosocial phenomenon that triggers systemic sympathetic stimulation, releasing catecholamines and cortisol that cause peripheral vasoconstriction, microvascular hypoxia, and delayed healing.

Classification of Wound Pain

Background Pain: Continuous, persistent pain experienced at rest, caused by underlying etiology (e.g., arterial ischemia, venous congestion, peripheral neuropathy).

Procedural Pain: Sharp, acute pain directly associated with wound management procedures, such as sharp debridement, dressing removal, cleansing, or dressing application.

Breakthrough Pain: Unexpected, sudden spikes in pain occurring secondary to movement, coughing, or muscle spasms.

Operative Pain: Acute pain associated with major surgical debridement, grafting, or amputation.

Multimodal Analgesic Strategies & WHO Pain Ladder

Step 1 (Mild Pain): Non-opioids (acetaminophen, NSAIDs) + adjuvants (gabapentin, pregabalin for neuropathic pain).

Step 2 (Moderate Pain): Weak opioids (hydrocodone, tramadol) ± non-opioids ± adjuvants.

Step 3 (Severe Pain): Strong opioids (morphine, oxycodone, fentanyl) ± non-opioids ± adjuvants.

Non-Pharmacologic & Dressing Strategies to Minimize Pain

Silicone & Contact Layer Interfaces: Utilizing soft silicone adhesives or non-adherent contact layers prevents mechanical stripping of delicate epidermal tissue during dressing changes.

Moist Dressing Removal: Saturating dried or adherent dressings with warm 0.9% normal saline prior to removal minimizes trauma and procedural pain.

Pre-Medication: Administering short-acting oral analgesics 30 to 60 minutes prior to scheduled debridement or dressing changes.

Topical Analgesia: Applying topical 2% lidocaine gel or EMLA cream (lidocaine 2.5%/prilocaine 2.5%) under occlusion 20 to 30 minutes before minor sharp debridement.

Patient Empowerment & Control: Granting the patient authority to call a "time-out" during painful procedures significantly reduces anxiety and pain perception.

Clinical Case Vignette

Clinical Scenario: An 74-year-old female resident of a long-term care facility is evaluated for a non-healing Stage 4 sacral pressure injury measuring 6.0 cm × 5.2 cm × 2.8 cm with exposed sacral bone. Laboratory evaluation reveals serum albumin 2.2 g/dL, serum prealbumin 9.0 mg/dL (severe malnutrition), and eGFR 65 mL/min/1.73m². She has been taking systemic prednisone 15 mg daily for rheumatoid arthritis for 5 years. She reports excruciating pain (8/10) during daily dressing changes.

Clinical Decision-Making:

Nutritional Scaling: Her severe malnutrition (prealbumin < 10 mg/dL) inhibits healing. The clinician orders a high-protein, high-calorie diet providing 30–35 kcal/kg/day and 1.2–1.5 g/kg/day protein .

Steroid Reversal: Because she takes chronic systemic corticosteroids, oral Vitamin A (10,000–25,000 IU/day for 7–10 days) is prescribed to reverse corticosteroid-induced inhibition of macrophage function and fibroplasia.

Micronutrient Support: Therapeutic Vitamin C (500 mg BID) and Zinc sulfate (220 mg daily for 14 days) are initiated.

Pain Management: To control procedural pain, the dressing change regimen is switched from dry gauze to a non-adherent soft silicone foam dressing, pre-medicating with an oral analgesic 45 minutes prior to dressing removal.